Pharmaceutical

Orion gets grant for cyp11a1 inhibitors for treating prostate cancer

Discover Orion Corp's groundbreaking patent for novel compounds targeting CYP11A1, offering new hope for treating prostate cancer and other androgen receptor-dependent conditions.

Aug 23, 2024 - 04:00
Discover Orion Corp's groundbreaking patent for novel compounds targeting CYP11A1, offering new hope for treating prostate cancer and other androgen receptor-dependent conditions.
Read the original article

Tags:

Previous Article

OptiBiotix Health gets grant for modified prebiotic oligosaccharides with increa...

Next Article

Ocular Therapeutix gets grant for intracanalicular injectable applicator device ...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Hospitals struggle to make money on CAR-T cancer therapies, but their fortunes may change

STAT+: Hospitals struggle to make money on CAR-T cancer...

Jul 20, 2023

WHO declares end of Covid-19 public health emergency

WHO declares end of Covid-19 public health emergency

May 6, 2023

FDA approves Astellas’ VYLOY for gastric cancer treatment

FDA approves Astellas’ VYLOY for gastric cancer treatment

Oct 22, 2024